Amyloid peptides with antimicrobial and/or microbial agglutination activity

Area of Science:

• Neuroscience
• Immunology
• Microbiology

Background:

• Brain infections are linked to amyloid deposits and neurodegeneration.
• Amyloid proteins, such as amyloid-beta (Aβ), function as innate immune effectors against infections.
• Amyloid peptides share mechanisms with antimicrobial peptides, including membrane disruption.

Purpose of the Study:

• To review and categorize the diverse roles and mechanisms of amyloid peptides in combating microbes.
• To explore amyloid peptides' antimicrobial activity and pathogen agglutination capabilities.
• To discuss the antimicrobial spectrum, effectiveness of different amyloid states (monomers, oligomers, fibrils), and cytotoxicity.

Main Methods:

• Literature review and synthesis of existing research on amyloid peptides and microbial interactions.
• Categorization of amyloid peptide mechanisms, including antimicrobial and agglutination functions.
• Analysis of factors influencing amyloid peptide efficacy, such as peptide state and cytotoxicity.

Main Results:

• Amyloid peptides demonstrate both direct antimicrobial activity and the ability to agglutinate microbes.
• Mechanisms include membrane disruption, bactericidal protein aggregation, and functional knockdown of microbial proteins.
• Pathogen agglutination by amyloid peptides is an increasingly recognized function.
• The effectiveness varies with amyloid peptide states (monomers, oligomers, fibrils) and is influenced by cytotoxicity.

Conclusions:

• Amyloid peptides possess significant antimicrobial and microbe-agglutinating characteristics.
• Recent discoveries highlight various mechanisms underlying amyloid peptides' anti-microbial actions.
• Amyloid peptides hold promise for the development of novel antimicrobial therapeutics.